Philips Respironics, Inc. has recalled approximately 154,564 ventilators, including Trilogy Evo, EV300, Aeris EVO, Garbin Evo, and LifeVent EVO2 models. These devices are used for breathing support in children and adults across hospital and home settings. The recall was initiated because using a medication-spraying device called a nebulizer in certain positions can cause medicine to build up on the internal sensor, leading to incorrect air flow measurements. No injuries have been reported at this time.
If the internal sensor provides inaccurate flow readings, the ventilator may not deliver the correct amount of air to the patient. This could lead to breathing difficulties or other serious health complications for patients who depend on the device.
You have 2 options:
Recall #: Z-0290-2025; Quantity: 24,249 units
Recall #: Z-0291-2025; Quantity: 82,800 units
Recall #: Z-0292-2025; Quantity: 9,999 units
Recall #: Z-0293-2025; Quantity: 34,146 units
Recall #: Z-0294-2025; Quantity: 804 units
Recall #: Z-0295-2025; Quantity: 1,322 units
Recall #: Z-0296-2025; Quantity: 1,244 units
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · FDA Press Release · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.